December 17, 2024 - 16:03

President-elect Trump has publicly defended his decision to appoint Robert F. Kennedy Jr. as the new secretary of health and human services. During his first news conference following the election, Trump faced questions regarding Kennedy's controversial stance on vaccines. In response, he expressed confidence in Kennedy's approach, stating, "I think he's going to be much less radical than you would think."
Kennedy, known for his vocal skepticism about vaccine safety, has sparked debate among health officials and the public alike. However, Trump emphasized that Kennedy’s expertise and experience in public health would be beneficial in addressing the nation’s health challenges. The president-elect's remarks suggest a belief that Kennedy's perspective could lead to a more balanced dialogue on health policies.
As the new administration prepares to take office, the appointment has raised eyebrows, but Trump remains steadfast in his choice, asserting that Kennedy's leadership will foster a constructive approach to health issues in the country.
July 30, 2026 - 02:45
Texas health issues alert after 4 Montgomery County residents infected with measlesTexas health authorities have issued a public health alert after four members of an unvaccinated family in Montgomery County tested positive for measles. The cases, all linked to a single household...
July 29, 2026 - 08:53
Local nonprofits call for changes at Bexar County jail over custody deaths, healthcare concernsHouston, Dallas, and San Antonio operate the three largest county jail systems in Texas. But so far this year, Bexar County has recorded the highest number of deaths among inmates in custody,...
July 28, 2026 - 17:12
Private Equity Firm Unloads Mental Health Chain Into Muni MarketA private equity firm based in Connecticut is moving to offload a network of mental health clinics and sober-living facilities, using a financing structure that taps into the municipal bond market....
July 28, 2026 - 03:52
Peptides are the latest wellness trend – but do they work?A US drug advisory committee has recently given a nod of approval to several experimental peptides, signaling a potential shift in how these compounds are viewed by regulators. Yet despite the...